The Vertical Group is a New Jersey-based venture capital firm focused on the fields of medical technology and biotechnology.
Business Model:
Revenue: $6.8M
Employees: 2-10
Address: 106 Allen Rd
City: Basking Ridge
State: NJ
Zip: 07920
Country: US
The Vertical Group is a venture capital firm focused on the fields of medical technology and biotechnology.
Contact Phone:
+19082773737
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
5/2010 | ENTrigue Surgical | Venture Round | 10.9M |
10/2010 | ProteinSimple | Series F | 20M |
12/2015 | Suture Concepts | Series D | 1M |
12/2014 | Suture Concepts | Series D | 3.8M |
6/2022 | MicroTransponder | Series E | 0 |
9/2004 | Vascular Architects | Series E | 0 |
10/2015 | Silk Road Medical | Private Equity Round | 57M |
3/2002 | BioSET | Series A | - |
10/2003 | OsteoBiologics | Venture Round | 9.2M |
10/2005 | PhotoThera | Series B | 19M |
1/2011 | TetraLogic Pharmaceuticals | Series C | 0 |
4/2013 | AtheroMed | Private Equity Round | 6M |
11/2002 | PhyFlex Networks | Series B | 0 |
4/2006 | Suture Concepts | Seed Round | 500k |
11/2022 | Luminopia | Seed Round | 0 |
5/2016 | Route 92 Medical | Venture Round | 5.9M |
5/2017 | Outset Medical | Series C | 0 |
12/2006 | Galil Medical | Venture Round | 52M |
4/2012 | AtheroMed | Private Equity Round | 13M |
7/2003 | Velocimed | Series C | 18M |
6/2007 | BioSET | Venture Round | 0 |
8/2004 | BioSET | Series B | 5M |
7/2003 | Bacchus Vascular | Series D | 25M |
1/2003 | Vascular Architects | Series D | 0 |
5/2006 | ViaCyte | Venture Round | 0 |
5/2009 | PhotoThera | Series D | 50M |
6/2008 | Meritage Pharma | Series A | 22.5M |
4/2006 | PhotoThera | Series C | 30.5M |
8/2011 | Suture Concepts | Series C | 1M |
12/2006 | Elron Ventures | Post-IPO Equity | 52M |
12/2020 | Carlsmed | Series A | 10M |
6/2007 | Tepha | Series B | 0 |
1/2006 | ProteinSimple | Series B | 0 |
3/2013 | Omada Health | Series A | 4.7M |
9/2008 | Proteolix | Series C | 79M |
4/2014 | Omada Health | Series B | 23M |
11/2008 | OncoMed Pharmaceuticals | Series B | 154M |
3/2018 | Biorez | Series C | 0 |
9/2020 | Biorez | Seed | 3.5M |
7/2017 | Silk Road Medical | Series C | 0 |
6/2006 | TetraLogic Pharmaceuticals | Series B | 36M |
11/2014 | Monteris Medical | Series B | 30M |
6/2015 | Outset Medical | Debt Financing | 45M |
5/2005 | Bayhill Therapeutics | Series B | 35.4M |
1/2004 | Bayhill Therapeutics | Series A | - |
11/2011 | Flexuspine | Series B | 2.1M |
9/2004 | Velocimed | Series D | 0 |
4/2007 | Bacchus Vascular | Venture Round | 6.5M |
5/2015 | Outset Medical | Series B | 60M |
4/2009 | ProteinSimple | Series C | 10M |
2/2007 | PhyFlex Networks | Private Equity Round | 0 |
1/2004 | PhyFlex Networks | Venture Round | 17.5M |
8/2010 | TetraLogic Pharmaceuticals | Series C | 0 |
6/2016 | Hinge Health | Seed Round | 1.3M |
9/2008 | ForteBio | Series C | 25M |
10/2005 | ForteBio | Series B | 17.3M |
9/1995 | CardioThoracic Systems | Venture Round | - |
4/2006 | Bayhill Therapeutics | Venture Round | 15.8M |
9/2005 | OncoMed Pharmaceuticals | Series A | 13.9M |
12/2021 | Route 92 Medical | Series E | 0 |
5/2007 | Silk Road Medical | Series A | 3.4M |
4/2012 | Silk Road Medical | Series B | 13M |
7/2017 | Hinge Health | Series A | 0 |
4/2022 | Carlsmed | Series B | 0 |
5/2017 | Home Dialysis Plus | Series C | 76.5M |
6/2022 | MicroTransponder | Series E | 0 |
4/2022 | Carlsmed | Series B | 0 |
12/2021 | Route 92 Medical | Series E | 0 |
12/2020 | Carlsmed | Series A | 0 |
9/2020 | Biorez | Seed Round | 0 |
3/2018 | Biorez | Series C | 0 |
7/2017 | Hinge Health | Series A | 0 |
7/2017 | Silk Road Medical | Series C | 0 |
5/2017 | Home Dialysis Plus | Series C | 0 |
5/2017 | Outset Medical | Series C | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|